These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8491007)

  • 1. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.
    Meijer A; Verheugt FW; Werter CJ; Lie KI; van der Pol JM; van Eenige MJ
    Circulation; 1993 May; 87(5):1524-30. PubMed ID: 8491007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis.
    Veen G; Meyer A; Verheugt FW; Werter CJ; de Swart H; Lie KI; van der Pol JM; Michels HR; van Eenige MJ
    J Am Coll Cardiol; 1993 Dec; 22(7):1755-62. PubMed ID: 8245325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
    Brouwer MA; van den Bergh PJ; Aengevaeren WR; Veen G; Luijten HE; Hertzberger DP; van Boven AJ; Vromans RP; Uijen GJ; Verheugt FW
    Circulation; 2002 Aug; 106(6):659-65. PubMed ID: 12163424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction.
    Kievit PC; Brouwer MA; Veen G; Karreman AJ; Verheugt FW
    Am Heart J; 2004 Nov; 148(5):826-33. PubMed ID: 15523313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial.
    Brouwer MA; Kievit PC; Dieker HJ; Veen G; Karreman AJ; Verheugt FW
    Am Heart J; 2008 Jun; 155(6):1039-46. PubMed ID: 18513517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling.
    Meijer A; Verheugt FW; van Eenige MJ; Werter CJ
    Circulation; 1994 Oct; 90(4):1706-14. PubMed ID: 7923654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome.
    van den Bergh PJ; Kievit PC; Brouwer MA; Aengevaeren WR; Veen G; Verheugt FW
    Am Heart J; 2009 Mar; 157(3):532-40. PubMed ID: 19249425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial). Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis.
    Veen G; de Boer MJ; Zijlstra F; Verheugt FW
    Am J Cardiol; 1999 Oct; 84(7):763-7. PubMed ID: 10513770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
    Ohman EM; Califf RM; Topol EJ; Candela R; Abbottsmith C; Ellis S; Sigmon KN; Kereiakes D; George B; Stack R
    Circulation; 1990 Sep; 82(3):781-91. PubMed ID: 2394002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse long-term effects of reocclusion after coronary thrombolysis.
    Brouwer MA; Böhncke JR; Veen G; Meijer A; van Eenige MJ; Verheugt FW
    J Am Coll Cardiol; 1995 Nov; 26(6):1440-4. PubMed ID: 7594068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reocclusion: the flip side of coronary thrombolysis.
    Verheugt FW; Meijer A; Lagrand WK; Van Eenige MJ
    J Am Coll Cardiol; 1996 Mar; 27(4):766-73. PubMed ID: 8613601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.
    White HD; French JK; Hamer AW; Brown MA; Williams BF; Ormiston JA; Cross DB
    J Am Coll Cardiol; 1995 Jan; 25(1):218-23. PubMed ID: 7798505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis.
    Roux S; Christeller S; Lüdin E
    J Am Coll Cardiol; 1992 Mar; 19(3):671-7. PubMed ID: 1531663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reocclusion three months after successful thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activating complex.
    Takens BH; Brügemann J; van der Meer J; den Heijer P; Lie KI
    Am J Cardiol; 1990 Jun; 65(22):1422-4. PubMed ID: 2191581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
    Reikvam A; Madsen S; Landmark K
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of aspirin alone with coumadin plus aspirin after provisional coronary stenting: final and follow-up results of a randomized study.
    Machraoui A; Germing A; von Dryander S; Lange S; Jäger D; Lemke B; Barmeyer J
    Am Heart J; 1999 Oct; 138(4 Pt 1):663-9. PubMed ID: 10502211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The smoker's paradox after successful fibrinolysis: reduced risk of reocclusion but no improved long-term cardiac outcome.
    Kievit PC; Brouwer MA; Veen G; Aengevaeren WR; Verheugt FW
    J Thromb Thrombolysis; 2009 May; 27(4):385-93. PubMed ID: 18581058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Harrington RA; Becker RC; Ezekowitz M; Meade TW; O'Connor CM; Vorchheimer DA; Guyatt GH
    Chest; 2004 Sep; 126(3 Suppl):513S-548S. PubMed ID: 15383483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.